FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS. EJHSMI. 2026;2(6):1-11. Accessed June 16, 2026. https://eurekaoa.com/index.php/5/article/view/1148